Hrt Financial LP 9 Meters Biopharma, Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.21 - $0.32 $2,955 - $4,504	14,075 New	14,075 $3,000
Q1 2022 May 16, 2022	SELL	$0.52 - $1.0 $6,907 - $13,283	-13,283 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.33 $11,290 - $17,666	13,283 New	13,283 $13,000
Q3 2021 Nov 15, 2021	SELL	$1.03 - $1.41 $25,190 - $34,484	-24,457 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.5 $570,906 - $823,423	-548,949 Reduced 95.73%	24,457 $26,000
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $481,661 - $1.24 Million	573,406 New	573,406 $670,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.